Complete Response of Highly Advanced Gastric Cancer with Peritoneal Dissemination after New Combined Chemotherapy of S-1 and Low-Dose Cisplatin: Report of a Case

Publisher： Karger

E-ISSN： 1423-0232|61|1|16-22

ISSN： 0030-2414

Source： Oncology, Vol.61, Iss.1, 2001-07, pp. : 16-22

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of S-1 plus Low-Dose Cisplatin for Unresectable and Recurrent Gastric Cancer (JFMC27-9902 Step2)

By  

Oncology, Vol. 79, Iss. 5-6, 2011-03 ,pp. : 337-342

Karger

Access to resources Recommend Favorite

Low-Dose Fulvestrant Maintained Long-Term Complete Remission after Poor Response to Previous Endocrine Therapies in a Patient with Advanced Breast Cancer

By  

Case Reports in Oncology, Vol. 3, Iss. 2, 2010-04 ,pp. : 131-136

Karger

Access to resources Recommend Favorite

A Multicenter, Phase I Dose-Escalating Study of Docetaxel, Cisplatin and S-1 for Advanced Gastric Cancer (KDOG0601)

By  

Oncology, Vol. 75, Iss. 1-2, 2008-08 ,pp. : 1-7

Karger

Access to resources Recommend Favorite

Response Predictors of S-1, Cisplatin, and Docetaxel Combination Chemotherapy for Metastatic Gastric Cancer: Microarray Analysis of Whole Human Genes

By  

Oncology, Vol. 93, Iss. 2, 2017-05 ,pp. : 127-135

Karger

Access to resources Recommend Favorite

Effect of Intensity Modulated Radiotherapy Combined with S-1-Based Chemotherapy in Locally Advanced Gastric Cancer Patients

By  

Oncology Research and Treatment, Vol. 37, Iss. 1-2, 2014-01 ,pp. : 11-16

Karger

Access to resources Recommend Favorite